Drug-Induced Pulmonary Arterial Hypertension: A More Complicated Prognosis
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.
Pulmonary Vascular Disorders
Pulmonary Arterial Hypertension Exacerbated by Traffic-Related Air Pollution
Traffic-related air pollution exposure has been linked to baseline disease severity in idiopathic/heritable pulmonary arterial hypertension.
Predicting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
Serum brain natriuretic peptide and echocardiographic evaluation performed at the time of bronchopulmonary dysplasia diagnosis can detect the development of late pulmonary hypertension in infants.
CMR-Determined RV Strain: A NonInvasive Test for Diastolic Stiffness in PH
CMR-determined RV strain may be a promising non-invasive method to assess RV-arterial coupling in PH.
Pregnancy-Adapted Algorithm Avoids Diagnostic Imaging for PE
Suspected pulmonary embolism safely ruled out in some pregnant women with diagnostic algorithm.
Balloon Pulmonary Angioplasty Safely Treats CTEPH in Older Patients
Balloon pulmonary angioplasty was considered safe and effective even in patients considered “oldest-old” with chronic thromboembolic pulmonary hypertension.
Gender, Age, and Etiology Do Not Affect Response to PAH Treatment
Age, gender, and etiology significantly influence prognosis together with the recently validated simplified PAH risk table but don’t significantly influence the response to PAH-specific treatment.
Better Guidelines for Diagnosing Pulmonary Embolism During Pregnancy Needed
Current guidelines to diagnosis pulmonary embolism in pregnant patients offer conflicting recommendations.
Heart-Lung vs Double-Lung Transplant Outcomes in Pulmonary Hypertension
Individuals with pulmonary hypertension experienced lower primary graft dysfunction following heart-lung transplantation compared with double-lung transplantation.
Pulmonary Arterial Hypertension Risk Better Predicted by REVEAL 2.0
The REVEAL 2.0 three category score was better at discriminating risks in patients with pulmonary arterial hypertension than similar tools such as COMPERA and FPHR.
Next post in Pulmonary Vasculature
